ESTUTC-5 New YorkLog in Sign up

LABT
Lakewood-Amedex Biotherapeutics Inc. Common Stock
stockNASDAQ

Market OpenNov 5, 2026 11:47:18 AM EST

0.68USD+255.192%(+0.49)536,323,793

Pre-marketNov 5, 2026 9:29:30 AM EST

0.3899USD+102.440%(+0.1973)

0.7000Bid0.7000Ask0.0000Spread

Loading…

Loading…

1.65M

Previous Close

$0.19

Beta

-0.09

52-Week High

$98.20 2026-04-23

52-Week Low

$0.17 2026-11-02

SMA 50

$1.27

SMA 200

$7.07

Avg. Vol 10D

7.86M

Avg. Vol 30D

4.23M

Avg. Vol 90D

2.70M

Relative Vol

36.94

2.37M

283,275

11.95%

90,040

Short Interest %

31.79%

1.00

On/Off Exchange

46%/54%

51.96%

Short Vol % (off-exch)

25.21%

212.3900%

0

20

26,374

218,302

Nov 12, 2026 (7d)

Jun 22, 2026 · 1-for-10 (reverse)

Nov 5, 2026

08:02 AM ESTLakewood-Amedex Biotherapeutics Announces Completion of Series C Convertible Preferred Stock Redemption ·

PR Newswire

Oct 21, 2026

08:02 AM EDTLakewood-Amedex Biotherapeutics Presents Data Highlighting Nu-3's Broad-Spectrum Antimicrobial Activity and Low Potential for Resistance at IDWeek 2026 ·

PR Newswire

Oct 7, 2026

08:02 AM EDTLakewood-Amedex Biotherapeutics Announces Positive Preclinical Data in Urinary Tract and Pulmonary Infection Indications with Bisphosphocin® Compounds ·

PR Newswire

Oct 1, 2026

08:02 AM EDTLakewood-Amedex Biotherapeutics Announces Participation in October Conferences ·

PR Newswire

Sep 28, 2026

12:16 PM EDTLABT: First Patient Dosed in Phase 2a Trial of Nu-3 for Infected Diabetic Foot Ulcers ·

Zacks Small Cap Research

LABT Performance

Period	Price	Date	Change	Beta
1W	0.24	2026-10-29	+193.64%	4.629
1M	0.85	2026-10-05	-18.49%	3.605
3M	2.31	2026-08-05	-69.83%	1.820
6M	31.00	2026-05-05	-97.75%	0.347
1Y	86.50	2026-04-23	-99.19%	-0.086

LABT Stock Summary

Lakewood-Amedex Biotherapeutics Inc. Common Stock (NASDAQ:LABT) stock price today is $0.70, and today's volume is 156,418,712. LABT is up 264.054% today. The 30 day average volume is 4.23M. LABT market cap is $1.65M with 2.37M shares outstanding.